These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18086947)

  • 1. Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?
    Biaggioni I
    Hypertension; 2008 Feb; 51(2):168-71. PubMed ID: 18086947
    [No Abstract]   [Full Text] [Related]  

  • 2. European Society of Hypertension Working Group on Obesity: background, aims and perspectives.
    Jordan J; Engeli S; Redon J; Sharma AM; Luft FC; Narkiewicz K; Grassi G;
    J Hypertens; 2007 Apr; 25(4):897-900. PubMed ID: 17351387
    [No Abstract]   [Full Text] [Related]  

  • 3. [How to treat effectively hypertensive patient with overactivity of sympathetic system?].
    Wańkowicz Z
    Pol Arch Med Wewn; 2002 Apr; 107(4):349-59. PubMed ID: 12189927
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenic factors in hypertension: therapeutic implications.
    Campese VM
    Ann Ital Med Int; 1994 Oct; 9 Suppl():39S-43S. PubMed ID: 7857755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hypertension complicated by diabetes mellitus and obesity].
    Kajiwara N
    Nihon Naika Gakkai Zasshi; 1990 Jan; 79(1):54-9. PubMed ID: 2324603
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.
    Engeli S; Sharma AM
    Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural mechanisms and management of obesity-related hypertension.
    Esler MD; Eikelis N; Lambert E; Straznicky N
    Curr Cardiol Rep; 2008 Nov; 10(6):456-63. PubMed ID: 18950554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxonidine well tolerated and effective in the treatment of viscerally obese, non-controlled hypertensive patients.
    Cardiovasc J S Afr; 2006; 17(4):209. PubMed ID: 17001427
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha Blockers and Metabolic Syndrome.
    Kabra NK
    J Assoc Physicians India; 2014 Sep; 62(9 Suppl):13-6. PubMed ID: 26245037
    [No Abstract]   [Full Text] [Related]  

  • 13. Centrally acting antihypertensives: not obsolete after all.
    Schachter M
    Int J Clin Pract; 1998; 52(3):192-5. PubMed ID: 9684437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary hypertension: obesity and the metabolic syndrome.
    Singer GM; Setaro JF
    J Clin Hypertens (Greenwich); 2008 Jul; 10(7):567-74. PubMed ID: 18607142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep apnea, aldosterone, and resistant hypertension.
    Pimenta E; Calhoun DA; Oparil S
    Prog Cardiovasc Dis; 2009; 51(5):371-80. PubMed ID: 19249443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic overdrive as the link among hypertension, obesity, and impaired thermogenesis: lights and shadows.
    Grassi G
    Hypertension; 2007 Jan; 49(1):5-6. PubMed ID: 17116757
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy for juvenile hypertension].
    Matsushita K; Umemura S
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):227-33. PubMed ID: 12652726
    [No Abstract]   [Full Text] [Related]  

  • 18. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction?
    Esler M; Rumantir M; Kaye D; Lambert G
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):139S-146S. PubMed ID: 11411749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obesity and hypertension. A dangerous liaison].
    MMW Fortschr Med; 2002 Oct; 144(43):57. PubMed ID: 12534023
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiology and treatment of the obesity-related arterial hypertension.
    Kolanowski J
    Acta Clin Belg Suppl; 1992; 14():18-25. PubMed ID: 1604957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.